3650--554-26-2-570-1646 Emergency Pharmacy 5 Lenalidomide 36F79720D0227 36C25926F0100 PO 554-A60293
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 36C25926F0100
- Agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36F79720D0227-36C25926F0100 Federal contract award
- Awardee
- Exelan Pharmaceuticals Inc.
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 issued a Limited/Sole Source Justification Notice for an emergency procurement of Lenalidomide, an essential cancer treatment medication used for leukemia, lymphoma, and multiple myeloma patients. The justification for sole-source procurement was based on an urgent and compelling medical need under RFO Subpart 538.7104-3(b)(1)(i), as the Rocky Mountain VA Medical Center in Aurora, Colorado faced immediate inventory insufficiency that posed direct risk to multiple patients requiring treatment continuity, with standard ordering procedures unable to meet the critical timeline. The contract was awarded to EXELAN PHARMACEUTICALS INC, located in Boca Raton, Florida, for a total value of $587,007.48 under Federal Supply Schedule Contract 36F79720D0227. Market research confirmed that Exelan Pharmaceuticals Inc. is the sole manufacturer and dispenser of the generic brand of Lenalidomide at the cost-effective level required, with items manufactured in the United States. The order (Line Item 5 under Purchase Order 554-A60293) was placed on February 5, 2026, with a delivery period from February 5 to February 8, 2026, and the medication was successfully delivered within the emergency timeframe to support critical patient care needs.
Notice text
Posting of Award Notice and Justification for an Emergency Pharmacy Buy for Lenalidomide against FSS contract. Awarded contract 36F79720D0227 to EXELAN PHARMACEUTICALS INC for 587007.48000000 on 2026-02-05.
Files
| File | Type | Posted |
|---|---|---|
| Emergency LSJ Order over SAT Redacted 1.pdf | ||
| 36F79720D0227 36C25926F0100_1.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity